These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 12414983)

  • 41. Influenza and Memory T Cells: How to Awake the Force.
    Spitaels J; Roose K; Saelens X
    Vaccines (Basel); 2016 Oct; 4(4):. PubMed ID: 27754364
    [TBL] [Abstract][Full Text] [Related]  

  • 42. In Vivo Validation of Predicted and Conserved T Cell Epitopes in a Swine Influenza Model.
    Gutiérrez AH; Loving C; Moise L; Terry FE; Brockmeier SL; Hughes HR; Martin WD; De Groot AS
    PLoS One; 2016; 11(7):e0159237. PubMed ID: 27411061
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Flow Cytometric and Cytokine ELISpot Approaches To Characterize the Cell-Mediated Immune Response in Ferrets following Influenza Virus Infection.
    DiPiazza A; Richards K; Batarse F; Lockard L; Zeng H; García-Sastre A; Albrecht RA; Sant AJ
    J Virol; 2016 Sep; 90(17):7991-8004. PubMed ID: 27356897
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Chronic spinal cord injury attenuates influenza virus-specific antiviral immunity.
    Bracchi-Ricard V; Zha J; Smith A; Lopez-Rodriguez DM; Bethea JR; Andreansky S
    J Neuroinflammation; 2016 May; 13(1):125. PubMed ID: 27245318
    [TBL] [Abstract][Full Text] [Related]  

  • 45. New Insights into the Generation of CD4 Memory May Shape Future Vaccine Strategies for Influenza.
    Devarajan P; Bautista B; Vong AM; McKinstry KK; Strutt TM; Swain SL
    Front Immunol; 2016; 7():136. PubMed ID: 27148257
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Competition within the virus-specific CD4 T-cell pool limits the T follicular helper response after influenza infection.
    Olson MR; Chua BY; Good-Jacobson KL; Doherty PC; Jackson DC; Turner SJ
    Immunol Cell Biol; 2016 Sep; 94(8):729-40. PubMed ID: 27101922
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Balancing Immune Protection and Immune Pathology by CD8(+) T-Cell Responses to Influenza Infection.
    Duan S; Thomas PG
    Front Immunol; 2016; 7():25. PubMed ID: 26904022
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The multifaceted role of CD4(+) T cells in CD8(+) T cell memory.
    Laidlaw BJ; Craft JE; Kaech SM
    Nat Rev Immunol; 2016 Feb; 16(2):102-11. PubMed ID: 26781939
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Induction of memory cytotoxic T cells to influenza A virus and subsequent viral clearance is not modulated by PB1-F2-dependent inflammasome activation.
    Lee PH; Bird N; MacKenzie-Kludas C; Mansell A; Kedzierska K; Brown L; McAuley J
    Immunol Cell Biol; 2016 May; 94(5):439-46. PubMed ID: 26667784
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Double-negative T resident memory cells of the lung react to influenza virus infection via CD11c(hi) dendritic cells.
    Neyt K; GeurtsvanKessel CH; Lambrecht BN
    Mucosal Immunol; 2016 Jul; 9(4):999-1014. PubMed ID: 26376363
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Measuring Cellular Immunity to Influenza: Methods of Detection, Applications and Challenges.
    Coughlan L; Lambe T
    Vaccines (Basel); 2015 Apr; 3(2):293-319. PubMed ID: 26343189
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Outcome Prediction in Mathematical Models of Immune Response to Infection.
    Mai M; Wang K; Huber G; Kirby M; Shattuck MD; O'Hern CS
    PLoS One; 2015; 10(8):e0135861. PubMed ID: 26287609
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Development of cross-protective influenza a vaccines based on cellular responses.
    Soema PC; van Riet E; Kersten G; Amorij JP
    Front Immunol; 2015; 6():237. PubMed ID: 26029218
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Design of a heterosubtypic epitope-based peptide vaccine fused with hemokinin-1 against influenza viruses.
    Shahsavandi S; Ebrahimi MM; Sadeghi K; Mahravani H
    Virol Sin; 2015 Jun; 30(3):200-7. PubMed ID: 25894902
    [TBL] [Abstract][Full Text] [Related]  

  • 55. CD8+ T cells complement antibodies in protecting against yellow fever virus.
    Bassi MR; Kongsgaard M; Steffensen MA; Fenger C; Rasmussen M; Skjødt K; Finsen B; Stryhn A; Buus S; Christensen JP; Thomsen AR
    J Immunol; 2015 Feb; 194(3):1141-53. PubMed ID: 25539816
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Longevity of B-cell and T-cell responses after live attenuated influenza vaccination in children.
    Mohn KG; Bredholt G; Brokstad KA; Pathirana RD; Aarstad HJ; Tøndel C; Cox RJ
    J Infect Dis; 2015 May; 211(10):1541-9. PubMed ID: 25425696
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Agonistic anti-CD40 promotes early development and increases the incidence of severe thyroid epithelial cell hyperplasia (TEC H/P) in CD4-/- mice.
    Yu S; Downey EF; Braley-Mullen H
    Immun Inflamm Dis; 2013 Oct; 1(1):14-25. PubMed ID: 25400914
    [TBL] [Abstract][Full Text] [Related]  

  • 58. CD28 expression is required after T cell priming for helper T cell responses and protective immunity to infection.
    Linterman MA; Denton AE; Divekar DP; Zvetkova I; Kane L; Ferreira C; Veldhoen M; Clare S; Dougan G; Espéli M; Smith KG
    Elife; 2014 Oct; 3():. PubMed ID: 25347065
    [TBL] [Abstract][Full Text] [Related]  

  • 59. CD4+ T cell help guides formation of CD103+ lung-resident memory CD8+ T cells during influenza viral infection.
    Laidlaw BJ; Zhang N; Marshall HD; Staron MM; Guan T; Hu Y; Cauley LS; Craft J; Kaech SM
    Immunity; 2014 Oct; 41(4):633-45. PubMed ID: 25308332
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Modeling the dynamics and migratory pathways of virus-specific antibody-secreting cell populations in primary influenza infection.
    Miao H; Sangster MY; Livingstone AM; Hilchey SP; Zhang L; Topham DJ; Mosmann TR; Holden-Wiltse J; Perelson AS; Wu H; Zand MS
    PLoS One; 2014; 9(8):e104781. PubMed ID: 25171166
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.